Drug Safety In France & Underreporting Of AEs

By Bart Cobert

There is a lively controversy underway in France right now regarding drug safety. To a certain degree this parallels what happened in the United States about 10 years ago when the FDA’s role and effectiveness in tracking drug safety was thrown into question. This led to investigations and changes in the law starting in 2007 bringing us to where we are today.

France has had two large controversies (or scandals as many call them) erupt in the last couple of years. And now there is a third, though so far smaller issue.